New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

XLVvsBBHETF Comparison

ETF 1
XLV

State Street Health Care Select Sector SPDR ETF

This fund is part of
US Health Care
-2%
Full XLV fund page
VS
ETF 2
BBH

VanEck Biotech ETF

This fund is part of
US Health Care
-2%
Full BBH fund page

State Street Health Care Select Sector SPDR ETF (XLV) and VanEck Biotech ETF (BBH) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. XLV is less expensive with a Total Expense Ratio (TER) of 0.08%, versus 0.35% for BBH. XLV is down -2.96% year-to-date (YTD) with +$900M in YTD flows. BBH performs better with 1.49% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of XLV and BBH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XLV vs BBH performance and flow charts

Performance

-4.0-3.0-2.0-1.00.01.02.03.0%Feb 11Feb 19Feb 26Mar 5Mar 12

Cumulative Flows

-800 M-600 M-400 M-200 M0 M200 M400 MFeb 11Feb 19Feb 26Mar 5Mar 12

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/12/2026
1M3MYTD1Y3Y5Y
Perf.
XLV
BBH
-3.74%-1.90%
-2.07%+0.58%
-2.96%+1.49%
+5.69%+19.17%
+25.97%+25.33%
+41.91%+12.69%
Flows
XLV
BBH
-$710M-$2M
-$28M-$2M
+$900M-$2M
-$38M-$58M
-$4.95B-$190M
+$6.87B-$121M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XLV
BBH
+14.03%+19.85%
+17.46%+22.37%
+13.62%+18.42%
+14.49%+21.47%
Max drawdown
XLV
BBH
-6.25%-6.07%
-12.43%-14.98%
-17.05%-22.78%
-17.05%-39.88%
Max drawdown duration
XLV
BBH
11d43d
211d128d
444d440d
444d1675d
Trading data

Create an account to view trading data

Join for free
XLV
BBH
Last sale
3/13/2026 at 3:27 PM
$150.33
$188.44
Previous close
03/12/2026
$150.16
$192.04
Consolidated volume
03/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XLV
BBH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/13/2026 at 3:27 PM
Live
Closed
XLV
BBH
Last price
$150.33
$188.44
1D performance
+0.11%
-1.87%
AuM$39.37 B$379.50 M
E/R0.08%0.35%
Characteristics
XLV
BBH
Management strategyPassivePassive
ProviderSPDRVanEck
BenchmarkS&P Health Care Select Sector IndexMVIS US Listed Biotech 25 Index
N° of holdings5722
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateDecember 16, 1998December 20, 2011
ESGNoNo
Advertisement
Exposure

Countries

XLV
USA
96.98%
Other
3.02%
BBH
USA
96.22%
Other
3.78%

Sectors

XLV
Health Care
98.26%
Other
1.74%
BBH
Health Care
89.47%
Other
10.53%
Advertisement

Diversification

XLV

Total weight of top 15 holdings out of 15

70.12%
BBH

Total weight of top 15 holdings out of 15

84.43%

Top 15 holdings

Data as of January 31, 2026
XLV
LILLY
14.69%
JOHNSON&JOHNSON
9.77%
ABBVIE
7.03%
MERCK & CO INC
4.88%
UNITEDHEALTH GRP
4.64%
THERMO FISHER SCIENTIFIC
3.88%
ABBOTT LABS
3.39%
AMGEN-T
3.28%
INTUITIVE SURGICAL
3.19%
GILEAD SCIENCES
3.14%
PFIZER
2.68%
BOSTON SCIENTIFIC
2.47%
DANAHER
2.45%
MEDTRONIC PLC
2.36%
STRYKER
2.27%
BBH
GILEAD SCIENCES
15.62%
AMGEN-T
15.10%
VERTEX PHARMACEUTICALS
9.14%
REGENERON PHARMACEUTICALS
7.18%
IQVIA HOLDINGS INC
4.54%
US04016X1019
4.53%
NATERA
4.13%
ALNYLAM PHARMACEUTICALS
3.69%
INSMED
3.57%
US07725L1026
3.50%
BIOGEN INC
3.02%
ILLUMINA
2.85%
UTD THERAPEUT
2.74%
MODERNA INC
2.41%
ICON PLC
2.40%
Frequently asked questions about XLV and BBH

How have the XLV and BBH ETFs performed in 2026?

As of March 12, 2026, XLV is down -2.96% year-to-date (YTD), while BBH has returned 1.49%. That puts BBH better performer ahead so far this year.

Which ETF is attracting more investor money: XLV or BBH?

Year-to-date, the XLV ETF saw +$900M in flows, compared to -$2M for BBH.

Which ETF is more volatile: XLV or BBH?

Over the past year, XLV had a volatility of 17.46%, while BBH experienced 22.37%.

Which ETF is bigger: XLV or BBH?

As of March 12, 2026, XLV holds $39.37 B in assets under management (AUM), while BBH manages $379.50 M.

What sectors do the XLV and BBH ETFs invest in?

XLV leans toward sectors like Health Care. Meanwhile, BBH focuses on Health Care.

What are the top holdings of the XLV ETF and BBH ETF?

XLV top holdings include LILLY, JOHNSON&JOHNSON and ABBVIE. BBH holds in its top three: GILEAD SCIENCES, AMGEN-T and VERTEX PHARMACEUTICALS.

Which ETF is more diversified: XLV or BBH?

XLV holds 60 securities with 70.12% of its assets in the top 15. BBH has 25 securities and a top 15 weight of 84.43%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up